Members |
targetComponentId |
Adult maltreatment syndrome NOS |
Adult victim of abuse (finding) |
Adverse reaction to adrenal cortical steroid NOS |
Corticosteroids adverse reaction |
Adverse reaction to analeptics NOS |
Central stimulant adverse reaction |
Adverse reaction to analgesics, anti-pyretics and anti-rheumatics NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to androgen or anabolic steroid NOS |
Androgen adverse reaction |
Adverse reaction to antacids and antigastric secretion drugs NOS |
Antacid adverse reaction |
Adverse reaction to anterior pituitary hormone NOS |
Adverse reaction to anterior pituitary hormone |
Adverse reaction to antibiotic NOS |
Antibacterial drug adverse reaction |
Adverse reaction to anticoagulant antagonist NOS |
Adverse reaction to anticoagulant antagonists |
Adverse reaction to anticoagulants NOS |
Anticoagulant adverse reaction |
Adverse reaction to anticonvulsants NOS |
Antiepileptic adverse reaction |
Adverse reaction to antidepressants NOS |
Antidepressant drug adverse reaction |
Adverse reaction to antidiarrheal drugs NOS |
Antidiarrheal drug adverse reaction |
Adverse reaction to antifungal antibiotics NOS |
Antifungal drug adverse reaction |
Adverse reaction to antihelminthic NOS |
Anthelmintics adverse reaction |
Adverse reaction to antihypertensives NOS |
Antihypertensive adverse reaction |
Adverse reaction to antilipemic and antiarteriosclerotic drugs NOS |
Lipid-lowering drug adverse reaction |
Adverse reaction to antimalarials NOS |
Antimalarial drug adverse reaction |
Adverse reaction to antimycobacterial antibiotic NOS |
Antimycobacterial agent adverse reaction |
Adverse reaction to antimycobacterial drug NOS |
Antimycobacterial agent adverse reaction |
Adverse reaction to antineoplastic and immunosuppressive drugs NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to antineoplastic antibiotics NOS |
Cytotoxic antibiotic adverse reaction (disorder) |
Adverse reaction to antiprotozoal drugs NOS |
Antiprotozoal drug adverse reaction |
Adverse reaction to antirheumatics NOS |
Adverse reaction to antirheumatic |
Adverse reaction to antithyroid agents NOS |
Antithyroid drug adverse reaction |
Adverse reaction to antitussive NOS |
Cough suppressant adverse reaction |
Adverse reaction to antivaricose drugs NOS |
Antivaricose agent adverse reaction |
Adverse reaction to antiviral drug NOS |
Antiviral drug adverse reaction |
Adverse reaction to aromatic analgesics NEC |
Analgesic adverse reaction |
Adverse reaction to aromatic analgesics NOS |
Analgesic adverse reaction |
Adverse reaction to beta-blockers NOS |
Beta-adrenoceptor blocking drug adverse reaction |
Adverse reaction to blood or blood products NOS |
Adverse reaction to blood or blood product |
Adverse reaction to bromine compounds NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to butyrophenone-based tranquilizers NOS (disorder) |
Butyrophenone adverse reaction |
Adverse reaction to capillary-active drugs NOS |
Adverse reaction to capillary-active drug |
Adverse reaction to carbonic acid anhydrase inhibitor NOS |
Carbonic anhydrase inhibitor adverse reaction |
Adverse reaction to cardiac rhythm regulator NOS |
Antiarrhythmic drug adverse reaction |
Adverse reaction to central nervous system stimulants NOS |
Central stimulant adverse reaction |
Adverse reaction to cephalosporin NOS |
Cephalosporin adverse reaction |
Adverse reaction to chloral hydrate group NOS |
Chloral hydrate adverse reaction |
Adverse reaction to chloramphenicol group NOS |
Chloramphenicol adverse reaction |
Adverse reaction to contrast media used for diagnostic X-rays NOS |
X-ray contrast media adverse reaction |
Adverse reaction to coronary vasodilators NOS |
Vasodilator adverse reaction |
Adverse reaction to diagnostic agents and kits NOS |
Diagnostic agent adverse reaction |
Adverse reaction to digestants NOS |
Adverse reaction to digestant |
Adverse reaction to diuretic NOS |
Diuretic adverse reaction |
Adverse reaction to drug or medicinal substance NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to emetics NOS |
Adverse reaction to emetic |
Adverse reaction to emollient cathartic NOS |
Adverse reaction to emollient cathartic |
Adverse reaction to enzymes NEC |
Adverse reaction to enzymes |
Adverse reaction to enzymes NOS |
Adverse reaction to enzymes |
Adverse reaction to erythromycin and other macrolides |
Macrolide adverse reaction |
Adverse reaction to expectorants NOS |
Cough suppressant adverse reaction |
Adverse reaction to fibrinolytic drugs NOS |
Adverse reaction to fibrinolytic drugs |
Adverse reaction to ganglion blockers NOS |
Adverse reaction to ganglion blocking drug |
Adverse reaction to gaseous anesthetic NOS |
Inhalational anesthetics adverse reaction |
Adverse reaction to hallucinogen NOS |
Adverse reaction to hallucinogen |
Adverse reaction to heavy metal anti-infectives NOS |
Bismuth chelate adverse reaction |
Adverse reaction to intravenous anesthetic NOS |
Intravenous anesthetics adverse reaction |
Adverse reaction to iron and iron compounds NOS |
Iron adverse reaction |
Adverse reaction to irritant cathartics NOS |
Adverse reaction to irritant cathartic |
Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations |
Topical agent adverse reaction (disorder) |
Adverse reaction to local anesthetics NOS |
Local anesthetic drug adverse reaction |
Adverse reaction to local anti-infective or anti-inflammatory drug NOS |
Anti-infectives adverse reaction |
Adverse reaction to macrolide NOS |
Macrolide adverse reaction |
Adverse reaction to mercurial diuretics NOS |
Mercurial diuretic adverse reaction |
Adverse reaction to mixed sedatives NEC |
Sedative adverse reaction |
Adverse reaction to non-narcotic analgesics NOS |
Analgesic adverse reaction |
Adverse reaction to opiate antagonists NOS |
Opioid antagonist adverse reaction |
Adverse reaction to opiates or related narcotics NOS |
Opioid analgesic adverse reaction |
Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to other and unspecified anti-infectives |
Anti-infectives adverse reaction |
Adverse reaction to other anti-infectives |
Anti-infectives adverse reaction |
Adverse reaction to other antibiotics |
Antibacterial drug adverse reaction |
Adverse reaction to other antibiotics NOS |
Antibacterial drug adverse reaction |
Adverse reaction to other anticonvulsant |
Antiepileptic adverse reaction |
Adverse reaction to other antihypertensives |
Antihypertensive adverse reaction |
Adverse reaction to other antimycobacterial drugs |
Antimycobacterial agent adverse reaction |
Adverse reaction to other antiprotozoal drugs |
Antiprotozoal drug adverse reaction |
Adverse reaction to other bacterial vaccines |
Adverse reaction to bacterial vaccine |
Adverse reaction to other cathartics including intestinal atonia drugs NOS |
Laxative adverse reaction (disorder) |
Adverse reaction to other cathartics, including intestinal atonia drugs |
Laxative adverse reaction (disorder) |
Adverse reaction to other central nervous system stimulants |
Central stimulant adverse reaction |
Adverse reaction to other diuretics |
Diuretic adverse reaction |
Adverse reaction to other drug or medicine NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to other gaseous anesthetics |
Inhalational anesthetics adverse reaction |
Adverse reaction to other general anesthetics |
General anesthetic drug adverse reaction |
Adverse reaction to other local anesthetics |
Local anesthetic drug adverse reaction |
Adverse reaction to other major tranquilizer (disorder) |
Sedative adverse reaction |
Adverse reaction to other mineral salts NEC |
Adverse reaction to inorganic chemical |
Adverse reaction to other non-narcotic analgesics |
Analgesic adverse reaction |
Adverse reaction to other sedatives and hypnotics |
Sedative adverse reaction |
Adverse reaction to other sedatives and hypnotics NOS |
Sedative adverse reaction |
Adverse reaction to other tranquilizers (disorder) |
Sedative adverse reaction |
Adverse reaction to other vaccines and biological substances |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Adverse reaction to other vasodilators |
Vasodilator adverse reaction |
Adverse reaction to other viral and rickettsial vaccines |
Adverse reaction to viral vaccine |
Adverse reaction to ovarian hormone or synthetic substitute NOS |
Sex hormones adverse reaction |
Adverse reaction to oxazolidine derivatives NOS |
Adverse reaction to oxazolidine derivative |
Adverse reaction to oxytocic agent NOS |
Adverse reaction to oxytocic agents |